Disease

An increased risk for Parkinson’s disease was associated with a range of factors, comorbidities and prodromal features, some of which may appear 5 to 10 years prior to diagnosis, according to a study in JAMA Neurology.

WASHINGTON — Patients with alcohol use disorder and diabetes mellitus or hepatitis C were at higher risk for advanced liver disease, while African American race had a protective effect, according to late-breaking data at The Liver Meeting.

Disruptions to care caused by the COVID-19 pandemic continued to negatively impact the fight against tuberculosis as cases and deaths have increased for the second year in a row after decades of declines, according to WHO’s 2022 Global TB Report.

Emergency response and recovery workers, law enforcement and construction workers who reported to the World Trade Center site after 9/11 had a twofold higher risk for myeloma precursor disease compared with the general population.

Increasing age, higher IOP and shallower anterior chamber depth were linked with elevated risk for primary angle-closure disease, according to a study in Ophthalmology.

Healthy dietary habits and an active lifestyle were associated with a lower rate of all-cause mortality in adults with Parkinson’s disease, according to a study published in JAMA Network Open.

In patients with relapsing-remitting multiple sclerosis, disease reactivation occurred within months of cessation of disease-modifying therapy but was reduced after starting a new treatment, according to a study published in Neurology.

New Zealand-based Toku Eyes has announced a U.S. expansion of its retinal imaging ORAiCLE technology, which can detect risk for heart attack and stroke, by 2025.

The first patient has been dosed in a phase 2 clinical trial investigating MCO-010 ambient light activatable optogenetic monotherapy for Stargardt disease, according to a press release from Nanoscope Therapeutics.

Experts from the fields of diabetes, cardiorenal and metabolic disease, and obesity will discuss new research and present practice recommendations at the 19th World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.